Endozepines are endogenous compounds with benzodiazepine like effects. They have been linked to hepatic encephalopathy and have controversially been linked to some cases of recurrent stupor.[1] Initially, the key diagnostic test is stupor which is sensitive to the benzodiazepine receptor antagonist flumazenil in the absences of exogenous benzodiazepines.
Potential candidates for these compounds are:[2]
- oleamides
- nonpeptidic endozepines such as inosine
- the protein Diazepam binding inhibitor (DBI)
References
- ↑ Cortelli, P.; Avallone, R.; Baraldi, M.; Zeneroli, ML.; Mandrioli, J.; Corsi, L.; Riva, R.; Tinuper, P.; et al. (Dec 2005). "Endozepines in recurrent stupor". Sleep Med Rev. 9 (6): 477–87. doi:10.1016/j.smrv.2005.07.003. PMID 16233983.
- ↑ Farzampour, Z; Reimer, RJ; Huguenard, J (2015). "Endozepines". Diversity and Functions of GABA Receptors: A Tribute to Hanns Möhler, Part A. Advances in Pharmacology (San Diego, Calif.). Vol. 72. pp. 147–64. doi:10.1016/bs.apha.2014.10.005. ISBN 9780128026601. PMC 4550098. PMID 25600369.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.